Wellbeing F.D.A. Rejects Closely Watched Lung Cancer Drug From China NYT Well · 15 November 2026 at 21:33 · 4 min read The treatment, called ivonescimab, has become a symbol of China’s rise in drug development. Read in Synapse Read on nytimes.com